Table 3.
Leptin and ghrelin concentrations at baseline and end of follow-up in patients infected with hepatitis C virus genotypes-1 and -3 by response to therapy, as well as mixed effect model derived estimates of differences in mean scores (mean ± SD)
Variable | Responders | Non-responders | P-value for the adjusted difference1 |
Leptin | |||
Baseline (ng/mL) | 30.99 (9.185) | 38.43 (11.58) | NS |
End of Follow-up (ng/mL) | 23.76 (8.055) | 34.10 (11.53) | 0.01 |
Ghrelin | |||
Baseline (ng/mL) | 0.532 (0.410) | 0.377 (0.223) | 0.01 |
End of Follow-up (ng/mL) | 0.438 (0.288) | 0.345 (0.237) | 0.05 |
Adjusted for both leptin and ghrelin concentrations. NS: Non-significant.